| Patient Demographics | Nodule Characteristics | Site of Recurrence | Time to Recurrence (days) |
| 48 Year Old Male | 16 mm LUL Perihilar | Site Recurrence | 439; Re-ablated |
| 71 Year Old Male | 18 mm RUL Peripheral Abutted Chest Wall | Chest Wall | 569; Chemotherapy & External Beam Radiation |
| 69 Year Old Female | 8 mm LUL Peripheral | Site Recurrence | 492; Re-ablated |
| 78 Year Old Female | 17 mm RUL Peripheral | Site Recurrence (first) | 368; Re-ablated |
|
|
| Hepatic Metastatic disease | 440; Cancer Mortality |
| 81 Year Old Male | 21 mm RUL Peripheral | Site Recurrence | 845; Re-ablated |
|
| 17 mm LLL Peripheral | Site Recurrence (first) | 248; Re-ablated |
|
|
| Site & N1 Recurrence | 313; Cancer Mortality |
| 64 Year Old Female | 20 mm RLL Abutted Chest Wall | Site & Chest Wall | 168; Chemotherapy & External Beam Radiation |
| 63 Year Old Male | 28 mm LUL Peripheral | Site & N1 Recurrence | 296; Chemotherapy |
| 88 Year Old Male | 13mm LUL Mid-lobar | Site Recurrence | 530; Re-ablated |
| 80 Year Old Female | 16 mm LUL Mid-lobar | M1a & N2 Recurrence | 350; Chemotherapy |
| 84 Year Old Male | 14 mm RUL Peripheral | M1; Widespread | 487; Chemotherapy |
| 70 Year Old Male | 19mm RLL Mid-lobar | Site Recurrence | 669; Chemotherapy |